EU Importation and MIA Support
Strengthening
EU market access for medicinal products through
controlled
certification
Schedule a consultation
Drug Product EU Importation.
We secure compliant, efficient, and reliable importation routes for medicinal products entering the European market.
Schedule a consultation
What we provide through our EU importation service.
- Full compliance with the Manufacturing and Importation Authorisation (MIA) framework.
- Assessment of your importation route to ensure alignment with EU directives and national competent authority expectations.
- Ensuring all importation processes meet EudraLex Volume 4 and GDP/GMP requirements.
- Comprehensive risk analyses for products, routes, partners, and distribution conditions.
- Gap analysis of existing systems to identify missing requirements for EU importation.
- Definition of corrective actions to reach full compliance and inspection readiness.
- Preparation, submission, and follow-up of regulatory dossiers, including variations and renewals.
- Ensuring alignment with EMA, CMDh, and national authority requirements.
- Support through regulatory lifecycle management to maintain compliant market presence.
- Ensuring your imported products meet EU pharmacovigilance requirements, including PSMF, signal detection, ICSRs, and periodic reports.
- Regulatory intelligence and vigilance to track evolving EMA and national authority expectations.
- Oversight of safety communication, quality defects, and recall strategy interactions.
- Guidance on strategies to enter or expand within the EU market.
- Alignment of regulatory pathways, dossier structure, and quality documentation.
- Support for interactions with EMA, AFMPS, and other competent authorities.
- Verification that suppliers, transporters, and warehouses meet GDP and GMP requirements before QP certification occurs.
- Review of CoA, CoC, temperature data, transport deviations, storage conditions, and supply chain documentation.
- Importation documentation compilation required for QP certification, without replacing QP decision-making.
- Ensuring full oversight of 2–8°C, −20°C, −70°C, and ultra-cold-chain importation conditions.
- Review and approval of transport lanes, qualification of partners, and oversight of deviations related to import activities.
- Implementation of quality agreements with third-country manufacturers and distributors.
- Coordination with customs, freight forwarders, and importation pathways.
- Ensuring documentation completeness, including shipping documents, proforma invoices, and import certificates.
- Follow-up until the batch is fully eligible for QP certification.
End-to-End EU Import Compliance
We ensure full regulatory adherence under the MIA framework, managing every step from EU entry to final QP certification.
Risk & Quality Excellence
Comprehensive quality, documentation, and risk assessments to guarantee GMP/GDP alignment before market release.
Accelerated Market Access
Fast, secure coordination with authorities (EMA, AFMPS) and efficient management of dossiers, variations, and vigilance activities.
Hundreds of batches imported and certified annually
Trusted by global manufacturers and MAHs worldwide
Over 20 years of combined QP import expertise
Fully integrated with your QA, RA, and Supply Chain systems
From third-country manufacturing to compliant EU market entry.
Support covers market entry, route redesign, MIA compliance, QP interface readiness, and the day-to-day control of complex imported products.
MAHs, importers, virtual companies, biotech teams, and distribution networks often need more than a release step. They need a coordinated framework covering quality systems, GDP and GMP interfaces, pharmacovigilance, and supply chain execution.
New launches into the European Union
A strong fit when a company is entering the EU for the first time and needs a practical importation route, aligned documentation, defined responsibilities, and a clear path to compliant market access.
Recovery of weak importation or MIA frameworks
Useful when the existing setup is fragmented, authority expectations are rising, or quality agreements, route controls, and documentation practices need remediation before they become inspection issues.
Ongoing continuity for high-risk and cold-chain products
Relevant when import activities depend on strict transport conditions, qualified partners, deviation control, and disciplined execution across third-country manufacturers and EU stakeholders.
Related expertise
QP / RP support | Inspection readiness | Read a technical article | Plan a consultation
Let’s define your next
compliance step
Share your context below and we will schedule a structured consultation to assess your regulatory and operational priorities.
